Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 22Recruiting 12Active not recruiting 10Withdrawn 5Terminated 3Unknown 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Carcinoma, Non-Small-Cell Lung 80Nasopharyngeal Carcinoma 51Uterine Cervical Neoplasms 43Lung Neoplasms 38Esophageal Neoplasms 31Head and Neck Neoplasms 28Esophageal Squamous Cell Carcinoma 27Squamous Cell Carcinoma of Head and Neck 22Stomach Neoplasms 20Breast Neoplasms 16Small Cell Lung Carcinoma 15Neoplasm Metastasis 12Nasopharyngeal Neoplasms 12Recurrence 11Carcinoma, Squamous Cell 10Ovarian Neoplasms 9Central Nervous System Neoplasms 9Neuroblastoma 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma 7Hypopharyngeal Neoplasms 7Triple Negative Breast Neoplasms 6Pancreatic Neoplasms 6Oropharyngeal Neoplasms 6Neoplasms 6Biliary Tract Neoplasms 6Urinary Bladder Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Follicular 5

Interventions

pembrolizumab 4anlotinib 4sintilimab 3Paclitaxel 3Leucovorin 3Cetuximab 3niraparib 2Sorafenib 2Radiotherapy 2Nivolumab 2Hyperthermic Intraperitoneal Chemotherapy 2Gemcitabine 2Fluorouracil 2Drug Therapy 2Docetaxel 2Cisplatin 2vistusertib 1titanium silicide 1tislelizumab 1tirbanibulin 1surufatinib 1regorafenib 1pemigatinib 1olaparib 1elemene 1durvalumab 1donafenib 1daromun 1avelumab 1aumolertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Carcinoma × Cisplatin × Clear all
NCT01855451 2022-11-18

HPVOropharynx

Trans Tasman Radiation Oncology Group

Phase 3 Unknown
189 enrolled
Tumor-Agnostic

Carcinoma

NCT00126269 2006-09-08

Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Unknown
192 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡